July 18, 2025

Decade of Data Validates Life’s Simple 7

A decade-long review supports that higher Life’s Simple 7 cardiovascular health scores significantly reduce risks of chronic disease, mortality, and health care use.

Conexiant

July 17, 2025

Semaglutide, Tirzepatide Linked to Lower Dementia Risk

Researchers found that semaglutide and tirzepatide were associated with reduced risks of dementia, stroke, and all-cause mortality in patients with type 2 diabetes and obesity.

Conexiant

July 14, 2025

Premenstrual Disorders Linked With Increased Risk of Cardiovascular Diseases 

A large Swedish study found that women diagnosed with premenstrual disorders had a modest but consistent increase in the risk of several types of cardiovascular diseases, including stroke, hypertension, and arrhythmia.

Conexiant

July 10, 2025

HHS Scraps Preventive Care Panel Meeting

HHS unexpectedly canceled a meeting of the U.S. Preventive Services Task Force, prompting fears it may be dismantled following similar moves by Secretary Robert F. Kennedy Jr. at other federal health agencies.

Conexiant

July 10, 2025

No Heart Risk Found With Triptan Use

A large real-world study found no significant increase in short-term heart attack or stroke risk among migraine patients using triptans, including those with cardiovascular risk factors.

Conexiant

July 09, 2025

Four Diagnostic Paths Found to Predict Alzheimer’s

A study of over 24,000 patients identified four common diagnostic paths that lead to Alzheimer’s disease, with multi-step sequences posing higher risk than single conditions and showing reproducibility in a national validation cohort.

Conexiant

July 09, 2025

Better Cholesterol Treatment Could Prevent Thousands of Cardiovascular Events

Most adults with high LDL cholesterol are not receiving recommended treatments and are not fully following clinical guidelines.

Conexiant

July 08, 2025

Mediterranean Diet’s 30-Year Legacy

A sweeping 30-year review confirms the Mediterranean-style diet lowers risks of heart disease, diabetes, cancer, and cognitive decline—while supporting global sustainability.

Conexiant

June 30, 2025

Breakthrough Device Approvals Outpacing Data

Many FDA-authorized breakthrough therapeutic devices may lack robust clinical testing.

Conexiant